Braulio A Marfil-Garza1, Ryekjang Kim2, A M James Shapiro1, Tatsuya Kin3. 1. Clinical Islet Transplant Program, University of Alberta, 210 College Plaza 8215-112 St, Edmonton, AB, T6G2C8, Canada. 2. Department of Pharmacology, University of Alberta, Edmonton, AB, Canada. 3. Clinical Islet Transplant Program, University of Alberta, 210 College Plaza 8215-112 St, Edmonton, AB, T6G2C8, Canada. tkin@ualberta.ca.
Abstract
BACKGROUND: Islet isolation is an essential process in every human islet transplantation protocol. Intraductal enzyme delivery followed by adequate distention of the pancreas is the most critical step in islet isolation. Anomalies of the pancreatic duct system can significantly affect this process. Thus, identification and characterization of ductal patency is of paramount importance to achieve optimal islet isolation. AIMS: To investigate the frequency of duct obliteration in the human pancreas and explore donor/patient characteristics associated with specific ductal variations. METHODS: We examined ductal patency of pancreata allocated for islet allotransplantation (n = 597) and autotransplantation (n = 21) after removal of the duodenum during islet isolation procedure. Donor/patient factors were reviewed from the batch files. RESULTS: Among 559 deceased donor pancreata without pancreas divisum (n = 38, 6.4%), both ducts were patent in 50.1%, only ventral duct was patent in 46.7%, and only dorsal duct was patent in 3.2%. Donor age was not associated with the frequency of obliterated dorsal duct. Black race tended to have the higher frequency of patent dorsal duct. As expected, pancreas divisum was more frequent in chronic pancreatitis cases (n = 6, 28.6%). Within 7 cases of chronic pancreatitis with unknown etiology, we encountered one case of ventral duct obliteration. CONCLUSIONS: The minor duodenal papilla and aging do not likely play an important role in the occurrence of dorsal duct obliteration. Although frequency of obliterated ventral duct was low in our population, physicians, including gastroenterologists and endoscopists, as well as islet transplantation researchers should be aware of this possibility.
BACKGROUND: Islet isolation is an essential process in every human islet transplantation protocol. Intraductal enzyme delivery followed by adequate distention of the pancreas is the most critical step in islet isolation. Anomalies of the pancreatic duct system can significantly affect this process. Thus, identification and characterization of ductal patency is of paramount importance to achieve optimal islet isolation. AIMS: To investigate the frequency of duct obliteration in the human pancreas and explore donor/patient characteristics associated with specific ductal variations. METHODS: We examined ductal patency of pancreata allocated for islet allotransplantation (n = 597) and autotransplantation (n = 21) after removal of the duodenum during islet isolation procedure. Donor/patient factors were reviewed from the batch files. RESULTS: Among 559 deceased donor pancreata without pancreas divisum (n = 38, 6.4%), both ducts were patent in 50.1%, only ventral duct was patent in 46.7%, and only dorsal duct was patent in 3.2%. Donor age was not associated with the frequency of obliterated dorsal duct. Black race tended to have the higher frequency of patent dorsal duct. As expected, pancreas divisum was more frequent in chronic pancreatitis cases (n = 6, 28.6%). Within 7 cases of chronic pancreatitis with unknown etiology, we encountered one case of ventral duct obliteration. CONCLUSIONS: The minor duodenal papilla and aging do not likely play an important role in the occurrence of dorsal duct obliteration. Although frequency of obliterated ventral duct was low in our population, physicians, including gastroenterologists and endoscopists, as well as islet transplantation researchers should be aware of this possibility.
Authors: Bojan Stimec; Tamara Alempijevic; Marjan Micev; Miroslav Milicevic; Tatjana Ille; Nada Kovacevic; Mirko Bulajic Journal: Ann Anat Date: 2005-04 Impact factor: 2.698
Authors: A B Lowenfels; P Maisonneuve; H Grover; E Gerber; M A Korsten; M T Antunes; A Marques; C S Pitchumoni Journal: Am J Gastroenterol Date: 1999-03 Impact factor: 10.864
Authors: Erwin J M van Geenen; Donald L van der Peet; Pranav Bhagirath; Chris J J Mulder; Marco J Bruno Journal: Nat Rev Gastroenterol Hepatol Date: 2010-08-10 Impact factor: 46.802
Authors: C Mel Wilcox; Bimaljit S Sandhu; Vikesh Singh; Andres Gelrud; Judah N Abberbock; Stuart Sherman; Gregory A Cote; Samer Al-Kaade; Michelle A Anderson; Timothy B Gardner; Michele D Lewis; Christopher E Forsmark; Nalini M Guda; Joseph Romagnuolo; John Baillie; Stephen T Amann; Thiruvengadam Muniraj; Gong Tang; Darwin L Conwell; Peter A Banks; Randall E Brand; Adam Slivka; David Whitcomb; Dhiraj Yadav Journal: Am J Gastroenterol Date: 2016-08-16 Impact factor: 10.864
Authors: Camillo Ricordi; Julia S Goldstein; A N Balamurugan; Gregory L Szot; Tatsuya Kin; Chengyang Liu; Christine W Czarniecki; Barbara Barbaro; Nancy D Bridges; Jose Cano; William R Clarke; Thomas L Eggerman; Lawrence G Hunsicker; Dixon B Kaufman; Aisha Khan; David-Erick Lafontant; Elina Linetsky; Xunrong Luo; James F Markmann; Ali Naji; Olle Korsgren; Jose Oberholzer; Nicole A Turgeon; Daniel Brandhorst; Xiaojuan Chen; Andrew S Friberg; Ji Lei; Ling-Jia Wang; Joshua J Wilhelm; Jamie Willits; Xiaomin Zhang; Bernhard J Hering; Andrew M Posselt; Peter G Stock; A M James Shapiro; Xiaojuan Chen Journal: Diabetes Date: 2016-07-27 Impact factor: 9.461